BRISTOL MYERS SQUIBB CO Income Tax Expense 2007-2026 | BMY
Beta
What is income tax expense?
Income tax expense is the total amount of income taxes a company owes to federal, state, and foreign governments.
What is BRISTOL MYERS SQUIBB CO's current income tax expense?
BRISTOL MYERS SQUIBB CO (BMY) annual income tax expense for 2025 was $2.27B, a 310.11% increase from 2024. BRISTOL MYERS SQUIBB CO income tax expense for the quarter ending March 31, 2026 was $561.0M.
What was BRISTOL MYERS SQUIBB CO's income tax expense in 2024?
BRISTOL MYERS SQUIBB CO annual income tax expense for 2024 was $554.0M, a 38.50% increase from 2023.
What was BRISTOL MYERS SQUIBB CO's income tax expense in 2023?
BRISTOL MYERS SQUIBB CO annual income tax expense for 2023 was $400.0M, a 70.76% decline from 2022.
What is BRISTOL MYERS SQUIBB CO's 5-year income tax expense CAGR?
BRISTOL MYERS SQUIBB CO income tax expense grew at a compound annual growth rate (CAGR) of 1.36% from FY2020 to FY2025, going from $2.12B to $2.27B over 5 years.
Income Tax Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+1.4%
FY2020
$2.12B
→
FY2025
$2.27B
07080910111213141516171819202122232425
5 years selected
Income Tax Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.27B | +310.1% | 10-K |
| FY2024 | $554.0M | +38.5% | 10-K |
| FY2023 | $400.0M | -70.8% | 10-K |
| FY2022 | $1.37B | +26.2% | 10-K |
| FY2021 | $1.08B | -49.0% | 10-K |
| FY2020 | $2.12B | +40.2% | 10-K |
| FY2019 | $1.51B | +48.4% | 10-K |
| FY2018 | $1.02B | -75.4% | 10-K |
| FY2017 | $4.16B | +195.2% | 10-K |
| FY2016 | $1.41B | +215.7% | 10-K |
| FY2015 | $446.0M | +26.7% | 10-K |
| FY2014 | $352.0M | +13.2% | 10-K |
| FY2013 | $311.0M | +293.2% | 10-K |
| FY2012 | $-161.0M | -109.4% | 10-K |
| FY2011 | $1.72B | +10.5% | 10-K |
| FY2010 | $1.56B | +31.8% | 10-K |
| FY2009 | $1.18B | +8.4% | 10-K |
| FY2008 | $1.09B | +131.4% | 10-K |
| FY2007 | $471.0M | - | 10-K |
Company: BRISTOL MYERS SQUIBB COTicker: BMYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →